Interesting OLN Put And Call Options For
Investors in Olin Corp. (Symbol: OLN) saw new options become available today, for the October 2026 expiration. One of the key inputs that goes into the price an option buyer
Featured News
More top news
In case you missed it
Connect with us
Recent Posts
Top of the month
For FY23, the Glucon-D maker’s standalone net profit stood at ?66 crore, a 400 percent jump from the previous fiscal Zydus wellness owns brands like Glucon D, Sugarfree and Nutralite. ‘); $(‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] < 0){ // $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); // $(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); //} if(resData[stkKey][‘percentchange’]
For FY23, the Glucon-D maker’s standalone net profit stood at ?66 crore, a 400 percent jump from the previous fiscal Zydus wellness owns brands like Glucon D, Sugarfree and Nutralite. ‘); $(‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] < 0){ // $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); // $(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); //} if(resData[stkKey][‘percentchange’]
USFDA inspected Zydus Lifesciences’ Onco injectable manufacturing plant in Ahmedabad from March 18 to 27 Zydus Lifesciences ‘); $(‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] < 0){ // $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); // $(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); //} if(resData[stkKey][‘percentchange’] >= 0){ $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $(‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] < 0){ $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); //$(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); $(‘#gainlosstxt_’+articleId).find(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); }
USFDA inspected Zydus Lifesciences’ Onco injectable manufacturing plant in Ahmedabad from March 18 to 27 Zydus Lifesciences ‘); $(‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] < 0){ // $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); // $(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); //} if(resData[stkKey][‘percentchange’] >= 0){ $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $(‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] < 0){ $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); //$(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); $(‘#gainlosstxt_’+articleId).find(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); }
Weekly Top
more news